4G Clinical, the leading provider of next-generation randomization and trial supply management (RTSM) technologies, is speaking at BSMA Europe on 23 May 2019 in Brussels, Belgium. 4G's VP of Strategy, Jan Pieter Kappelle, will give a presentation on how to increase real time visibility, scenario planning and control over supply decisions in highly complex Cell & Gene clinical trials.
BSMA Europe convenes stakeholders from biotech, biopharma, and biomedical device to examine best practices and discuss topics such as digitalization, challenges for the cell and genes therapies, how to build excellence in commercial supply chains (from sourcing to distribution), mitigating the risks and navigating in an unstable environment.
Vice President, Strategy
Thursday, 23 May at 13:30
in Clinical Trials
Demystifying the use of Innovative RTSMs in a Highly Regulated Environment
Clinical Supply Planning
Addressing Gaps in People, Process and Technology to Drive Supply Chain Efficiencies
Site Forecasting – Enabled by Confidence Dials
Informing Forecasting and Resupply Decisions Based on Business Needs Rather than Complex Calculations